A&G Pharmaceutical Inc
Business Identifier: GP88 Antibody for Treatment of Cancer
Public Profile:
A&G Pharmaceutical, Inc. discovers, develops, and commercializes theranostic products and drug/test combinations that enhance screening, detection, and treatment of cancer and other human diseases in the United States. The company primarily focuses on developing molecular tests that detect cancer at earlier stages when it is treatable and associated treatments that precisely target and destroy cancer. It offers GP88/progranulin, a biomarker produced by breast cancer tumors and used to help the cancer grow and proliferate. The company provides GP88-based breast cancer diagnostic test kits to enhance early detection, diagnosis, and treatment of breast cancer. It also focuses on developing anti-GP88 monoclonal antibody therapeutics; and screening for monoclonal antibodies that recognize ovarian, pancreatic, prostate, and lung cancer.

 Synopsis: Awardee Business Condition
Year Founded IP Holdings
Employee Range VC funded?
Revenue Range Private/Public
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Igf::Ot::Igftitle: Smart Fusion: High Affinity Peptide Capture Reagentspop: 0
Targeted Therapy For Non Small Cell Lung Carcinoma: In Vivo Feasibility Studies
Novel Agent To Restore Sensitivity To Anti-Estrogen Therapy
Serum Gp88 Biomarker As A Surrogate Marker For Disease Progression In Breast Canc
Novel Targeted Therapy For Breast Cancer